Open Orphan #ORPH / hVIVO Signs Contract with UK Government for the Development of a COVID-19 Human Challenge Study Model
Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company, which is the world leader in the testing of vaccines and antivirals using human challenge studies, is pleased to announce the signing of a contract by hVIVO, a subsidiary of Open Orphan, with the UK Government to develop a COVID-19 (SARS-CoV-2) human challenge […]
Alan Green presents the investment case for Open Orphan #ORPH and British Honey Company #BHC on his weekly Stockbox Media Research talk
Alan Green presents the investment case for Open Orphan #ORPH and British Honey Company #BHC on his weekly Stockbox Media Research talk
Open Orphan #ORPH – Statement re further media comment on UK Government and other partners for a UK Coronavirus challenge study
Further to our announcement of 24 September 2020 and further media comment the Company confirms that it remains in advanced negotiations with the UK Government and other partners for a Coronavirus challenge study in the UK. No contract has been signed and the Company will update the market in due course as appropriate. For further […]
Most people try to avoid Covid-19. But thousands are signing up to be deliberately exposed – CNN
By Mick Krever, Phil Black and Cristiana Moisescu, London (CNN) – As most of us obsess with avoiding Covid-19 at all costs, a rapidly growing group of people around the world say they are prepared to deliberately take on the virus. Tens of thousands of people have signed up to a campaign by a group called 1 Day Sooner to […]
Alan Green on Trump/Biden, plus Open Orphan #ORPH, Erris Resources #ERIS & Tertiary Minerals #TYM on the UK Investor Mag podcast
Alan Green discusses the Trump/Biden effect on the markets, plus Open Orphan #ORPH, Erris Resources #ERIS and Tertiary Minerals #TYM with Jonathan Roy on the UK Investor Magazine podcast.
Open Orphan #ORPH – Interim Results for 6 months ended 30 June, will be operationally profitable in Q4
Open Orphan Plc, a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical studies is pleased to announce its interim results for the six months ended 30 June 2020. The interim results include the first six months of hVIVO group (“hVIVO”) following its […]
The Times – Trial to infect British volunteers with modified coronavirus at hVIVO Quarantine Centre
Scientists are planning to infect British volunteers with a weakened, computer-designed form of the coronavirus, which researchers believe could work as a vaccine. The early-stage trial will take place in a special 24-bed quarantine clinic in Whitechapel, east London. The US biotech company behind it, Codagenix, is in talks with UK regulators and expects to […]
Alan Green discusses Open Orphan #ORPH, Kingfisher #KGF & Castillo Copper #CCZ on Vox Markets podcast
Alan Green discusses Open Orphan #ORPH, Kingfisher #KGF & Castillo Copper #CCZ with Justin Waite on the Vox Markets podcast. Interview starts at 10 minutes 42 seconds.
Open Orphan #ORPH – New £4.3m Challenge Study Contract Win with Global Top 10 Vaccine Company
Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is pleased to announce a new £4.3 million contract to conduct a human viral challenge study utilising one of our 8 traditional challenge study models for another […]
Open Orphan #ORPH – Exercise of Investor Warrants by Investor, Issue of Shares and Total Voting Rights
Open Orphan plc (ORPH), the rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models, has received a notice of exercise of warrants by an investor who participated in the Venn loan note financing in December 2018 over 269,866 ordinary shares of 0.1 pence […]